• 0161 536 4008

  • mandy@dermexpert.co.uk

  • 76 King Street, M24NH

Rosacea Update

MIRVASO® (brimonidine) topical gel, 0.33%* is the first and only FDA-approved treatment developed and indicated for persistent facial redness of rosacea. Facial redness is a common symptom of rosacea, a skin condition that affects an estimated 16 million Americans.

 

Galderma_BeforeAfter_-Mirvaso

Contact Dr Clayton for further information….

Derm Expert